Effect of Food, an Antacid, and the H 2 Antagonist Ranitidine on the Absorption of BAY 59–7939 (Rivaroxaban), an Oral, Direct Factor Xa Inhibitor, in Healthy Subjects von Kubitza, Dagmar, Becka, Michael, Zuehlsdorf, Michael, Mueck, Wolfgang

Volltext

Rivaroxaban (BAY 59‐7939) – an oral, direct Factor Xa inhibitor – has no clinically relevant interaction with naproxen von Kubitza, Dagmar, Becka, Michael, Mueck, Wolfgang, Zuehlsdorf, Michael

Volltext

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban-an Oral, Direct Factor Xa Inhibitor-Are Not Affected by Aspirin von Kubitza, Dagmar, Becka, Michael, Mueck, Wolfgang, Zuehlsdorf, Michael

Volltext

Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape von Simard, Manon A, Cabrera-Galvez, Carlos, Viteri, Santiago, Geist, Felix, Reischmann, Nadine, Zühlsdorf, Michael, Karachaliou, Niki

Volltext

Mapping combinatorial drug effects to DNA damage response kinase inhibitors von Zhang, Hanrui, Kreis, Julian, Schelhorn, Sven-Eric, Dahmen, Heike, Grombacher, Thomas, Zühlsdorf, Michael, Zenke, Frank T., Guan, Yuanfang

Volltext

Abstract 6776: Spatial transcriptomics of response to tepotinib treatment in a patient with NSCLC von Simard, Manon A., Geist, Felix, Cabrera, Carlos, Viteri, Santiago, Albers, Joachim, Zuehlsdorf, Michael, Karachaliou, Niki

Volltext

RosettaSX: Reliable gene expression signature scoring of cancer models and patients von Kreis, Julian, Nedić, Boro, Mazur, Johanna, Urban, Miriam, Schelhorn, Sven-Eric, Grombacher, Thomas, Geist, Felix, Brors, Benedikt, Zühlsdorf, Michael, Staub, Eike

Volltext

Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses von Uhl, Wolfgang, Zühlsdorf, Michael, Koernicke, Thomas, Forssmann, Ulf, Kovar, Andreas

Volltext

A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Meta... von Wirth, Manfred, Heidenreich, Axel, Gschwend, Jürgen E, Gil, Thierry, Zastrow, Stefan, Laniado, Michael, Gerloff, Joachim, Zühlsdorf, Michael, Mordenti, Giacomo, Uhl, Wolfgang, Lannert, Heinrich

Volltext

In vivo optical imaging of CD13/APN-expression in tumor xenografts von von Wallbrunn, Angelika, Waldeck, Jens, Höltke, Carsten, Zühlsdorf, Michael, Mesters, Rolf, Heindel, Walter, Schäfers, Michael, Bremer, Christoph

Volltext

Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer w... von Wirth, Manfred, Heidenreich, Axel, Gschwend, Jürgen E., Gil, Thierry, Zastrow, Stefan, Laniado, Michael, Zuehlsdorf, Michael, Gerloff, Joachim, Uhl, Wolfgang, Lannert, Heinrich

Volltext

Effects of Single-Dose BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor - in Subjects with Extreme Body Weight von Kubitza, Dagmar, Becka, Michael, Zuehlsdorf, Michael, Mueck, Wolfgang

Volltext

Naproxen Has No Relevant Effect on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor von Kubitza, Dagmar, Becka, Michael, Mueck, Wolfgang, Zuehlsdorf, Michael

Volltext

Effects of Renal Impairment on the Pharmacology of Rivaroxaban (BAY 59-7939) - An Oral, Direct, Factor Xa Inhibitor von Halabi, Atef, Maatouk, Haidar, Klause, Norbert, Lufft, Volkmar, Kubitza, Dagmar, Zuehlsdorf, Michael, Becka, Michael, Mueck, Wolfgang, Schäfers, Rafael, Wand, Dominic, Philipp, Thomas, Bruck, Heike

Volltext

CFU-GM Content of Bone Marrow Graft Correlates With Time to Hematologic Reconstitution Following Autologous Bone Marrow Transplantation With 4-Hydroperoxycyclophosphamide-Purged Bo... von Scott D., Rowley, Zuehlsdorf, Michael, Braine, Hayden G., Colvin, O. Michael, Davis, Janice, Jones, Richard J., Saral, Rein, Sensenbrenner, Lyle L., Yeager, Andrew, Santos, George W.

Volltext

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER von Reindl, Juergen, Groll, Karin, Pfaff, Otmar, Zuehlsdorf, Michael, Hoffmann, Axel, Pipp, Frederic Christian, Brischwein, Klaus, Raab, Sabine, Dau, Ulrike, Lannert, Heinrich, Destenaves, Benoit

Volltext bestellen

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER von Groll, Karin, Pfaff, Otmar, Zuehlsdorf, Michael, Hoffmann, Axel, Pipp, Frederic Christian, Reindl, Jürgen, Brischwein, Klaus, Raab-Westphal, Sabine, Dau, Ulrike, Lannert, Heinrich, Destenaves, Benoit

Volltext bestellen

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER von PFAFF, OTMAR, ZUEHLSDORF, MICHAEL, HOFFMANN, AXEL, BRISCHWEIN, KLAUS, RAAB, SABINE, REINDL, JÜRGEN, DAU, ULRIKE, GROLL, KARIN, LANNERT, HEINRICH, PIPP, FREDERIC, CHRISTIAN, DESTENAVES, BENOIT

Volltext bestellen

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER von Groll, Karin, Pfaff, Otmar, Zuehlsdorf, Michael, Hoffmann, Axel, Pipp, Frederic Christian, Reindl, Jürgen, Brischwein, Klaus, Raab, Sabine, Dau, Ulrike, Lannert, Heinrich, Destenaves, Benoit

Volltext bestellen

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF PROSTATE CANCER von GROLL Karin, DESTENAVES Benoit, PFAFF Otmar, RAAB Sabine, REINDL Jurgen, LANNERT Heinrich, PIPP Frederic Christian, HOFFMANN Axel, DAU Ulrike, ZUEHLSDORF Michael, BRISCHWEIN Klaus

Volltext bestellen